Evaluating the safety, pharmacokinetics and efficacy of phage therapy in treating fracture-related infections with multidrug-resistant Staphylococcus aureus: intravenous versus local application in sheep

PT is a safe adjunct to antibiotic treatment for FRI, however, phage neutralization developed rapidly and was accelerated in infected hosts. Further research is required to optimize phage selection, dosing, and delivery methods to enhance its therapeutic potential as an adjunct to conventional antibiotic therapy, particularly in the face of challenges such as rapid clearance and phage neutralization.

Authors

Institutions

Publication Details

Journal
Frontiers in Cellular and Infection Microbiology
Published
2025-04-04
DOI
https://doi.org/10.3389/fcimb.2025.1547250
Citations
8
Primary Topic
Bacteriophages and microbial interactions
Type
article
Field-Weighted Citation Impact
13.73
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluating the safety, pharmacokinetics and efficacy of phage therapy in treating fracture-related infections with multidrug-resistant Staphylococcus aureus: intravenous versus local application in sheep

Daniel Arens, T. Fintan Moriarty, M.H.J. Verhofstad, Charalampos G. Zalavras et al.
8 citations
Frontiers in Cellular and Infection Microbiology
Bacteriophages and microbial interactions
13.73
article

Evaluating the safety, pharmacokinetics and efficacy of phage therapy in treating fracture-related infections with multidrug-resistant Staphylococcus aureus: intravenous versus local application in sheep

Daniel Arens, T. Fintan Moriarty, M.H.J. Verhofstad, Charalampos G. Zalavras, Jolien Onsea, Michael J. Raschke, Marco Chittò, Christian Peez, Caroline Constant, William Todd Obremskey, Leopold Henssler, Andrej Trampuž, Stephan Zeiter, Willem‐Jan Metsemakers, Baixing Chen
article en
8 citations

Abstract

PT is a safe adjunct to antibiotic treatment for FRI, however, phage neutralization developed rapidly and was accelerated in infected hosts. Further research is required to optimize phage selection, dosing, and delivery methods to enhance its therapeutic potential as an adjunct to conventional antibiotic therapy, particularly in the face of challenges such as rapid clearance and phage neutralization.

Frontiers in Cellular and Infection MicrobiologyVol. 15
University of Southern California (US), Queensland University of Technology (AU), AO Foundation (CH), Erasmus MC (NL), University Hospital Regensburg (DE), Los Angeles Medical Center (US), University Hospital Münster (DE), Vanderbilt University Medical Center (US), KU Leuven (BE)
Good health and well-being
Openalex Percentile: Top 1%
Bacteriophages and microbial interactions
13.73
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.